DXC-005

N/A

Report date: 2024/04/22 14:59:24

Base Information

Drug NameDXC-005

Drug Alias NameRecombinant humanized anti-Muc1 antibody conjugated to Tub201重组人源化抗Muc1单抗-Tub201偶联剂DXC-005

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > Disulfide bond linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Tub201 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-MUC1

TargetsMucin-1

Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesHangzhou Dac Biotech Company Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou Dac Biotech Company Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumoursPancreatic NeoplasmsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A